Lanean...
Liver-targeted antiviral peptide nanocomplexes as potential anti-HCV therapeutics
Great success in HCV therapy was achieved by the development of direct-acting antivirals (DAA). However, the unsolved issues such as high cost and genotype dependency drive us to pursue additional therapeutic agents to be used instead or in combination with DAA. The cationic peptide p41 is one of su...
Gorde:
| Argitaratua izan da: | Biomaterials |
|---|---|
| Egile Nagusiak: | , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2015
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4562313/ https://ncbi.nlm.nih.gov/pubmed/26298393 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biomaterials.2015.08.014 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|